Dig Dis Sci. 2008; 53(8): 2258–2267. 2. Lenhart M, Paetzel C, Sackmann M, et al. Superselective arterial embolisation with a liquid polyvinyl alcohol copolymer in patients with acute gastrointestinal haemorrhage. Eur Radiol. 2010; 20:1994–1999. 3. Tian X, Shi Y, Hu Y, et al. Percutaneous transhepatic variceal embolization with cyanoacrylate vs. transjugular intrahepatic portal systemic shunt for esophageal variceal bleeding. Hepatol Int. 2013; 7(2): 636–644. 4. Sun A, Shi YJ, Xu XG, et al. MDCT angiography to evaluate the therapeutic
effect of PTVE for esophageal varices. World J Gastroenterol. INCB024360 2013; 19(10): 1563–1571. EH TSOI,1 CY GOH,1 N PARTHASARATHY,1 KE MARION,3 C MCNAB,1 S GLANCE,1 C LEUNG2 1Department of Gastroenterology, The Northern Hospital, Northern Health, Victoria, Australia,
2University of Melbourne, Doxorubicin clinical trial Melbourne, Victoria, Australia, 3School of Mathematical and Geospatial Sciences College of Science, Engineering and Health, RMIT University, Victoria, Australia Introduction: Current American Association for the Study of Liver Diseases guidelines recommend hepatitis B virus (HBV) screening with hepatitis B surface antigen (HBsAg), hepatitis B surface antibody (antiHBs) and hepatitis B core antibody (antiHBc) in all persons born in high and intermediate endemic areas. Our aim is to audit the screening practices for HBV infection in at-risk patients who attended a metropolitan hospital inflammatory bowel disease clinic. Methods: All patients born in high and intermediate endemic areas with inflammatory bowel disease (IBD) who attended an IBD clinic between January 2012 and January 2014 were identified from clinic records
based on country of birth. Medical records and hospital laboratory results were reviewed; and general practitioners were contacted to determine hepatitis screening practices. Multivariate analysis was used to determine if there were any factors that predicted screening for HBV in these patients. 上海皓元医药股份有限公司 Results: 70 patients who attended IBD clinic between 2012 and 2014 were identified to be from high and intermediate endemic areas. 44% were male with a median age of 55 years. 50% of patients had Crohn’s disease and 50% had ulcerative colitis. The majority of patients were born in Turkey (16%), Italy (13%) and Greece (7%). Only thirty-eight patients (54%) had hepatitis B serology performed and of these, 36 (95%) had HBsAg, 19 (50%) had antiHBs and 20 (53%) had antiHBc tested. Patients with Crohn’s disease were more likely to be tested compared to those with ulcerative colitis (60% vs 45% respectively, p = 0.048). Gender and country of birth did not affect screening practices for HBV infection (p = 0.141 & p = 0.168 respectively).